Eosinophilia Reflects Type 2 Immune Activation in Newly Diagnosed Bullous Pemphigoid, With No Evidence of Charcot‐Leyden Crystals
Allergy · 2026-07-09
DOI: 10.1111/all.70443 ↗At a glance
Leserbrief in Allergy, published online on 2026-07-09. Written by Janik Fleißner and 4 co-authors. Institution: Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany. 10 references. The full text is freely available (open access, CC BY 4.0). Funded by: Else Kröner-Fresenius-Stiftung, Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
Author keywords
Authors and institutions
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
ORCID profiles: Janik Fleißner, Tassilo Dege
Funding
- Else Kröner-Fresenius-Stiftung
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
Cite
APA
Fleißner, J., Dege, T., Benoit, S., Goebeler, M., & Kerstan, A. (2026). Eosinophilia Reflects Type 2 Immune Activation in Newly Diagnosed Bullous Pemphigoid, With No Evidence of Charcot‐Leyden Crystals. Allergy. https://doi.org/10.1111/all.70443
Vancouver
Fleißner J, Dege T, Benoit S, Goebeler M, Kerstan A. Eosinophilia Reflects Type 2 Immune Activation in Newly Diagnosed Bullous Pemphigoid, With No Evidence of Charcot‐Leyden Crystals. Allergy. 2026. doi:10.1111/all.70443
BibTeX
@article{Fleiner2026,
author = {Fleißner, Janik and Dege, Tassilo and Benoit, Sandrine and Goebeler, Matthias and Kerstan, Andreas},
title = {Eosinophilia Reflects Type 2 Immune Activation in Newly Diagnosed Bullous Pemphigoid, With No Evidence of Charcot‐Leyden Crystals},
journal = {Allergy},
year = {2026},
doi = {10.1111/all.70443}
}
EUVIMED